Evidence for an exclusive association of matrix metalloproteinase-9 with dysfunctional high-density lipoprotein: a

S Sini1, D Deepa1, S Harikrishnan2

  • 1Department of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala 695011, India.

Atherosclerosis
|July 24, 2014
PubMed

Insights

Dysfunctional high-density lipoprotein (HDL) is linked to increased matrix metalloproteinase-9 (MMP-9) activity, promoting inflammation and potentially increasing cardiovascular disease risk.

Area of Science:

  • Cardiovascular Science
  • Lipoprotein Metabolism
  • Inflammation Biology

Background:

  • High-density lipoprotein (HDL) possesses antiatherogenic functions, but these can be impaired during atherosclerosis and systemic inflammation.
  • HDL dysfunction has been observed even in healthy individuals experiencing systemic inflammation.
  • Previous research linked dysfunctional HDL to acute-phase proteins.

Purpose of the Study:

  • To investigate the association between dysfunctional HDL and pro-inflammatory proteins beyond acute-phase proteins.
  • To explore the role of matrix metalloproteinase-9 (MMP-9) in HDL dysfunction.

Main Methods:

  • Serum HDL isolated using density gradient ultracentrifugation, PEG precipitation, and electroelution.
  • HDL antioxidant property assessed via LDL oxidation assay.
  • MMP-9 activity evaluated using gelatin zymography and Western blot.

Main Results:

  • Dysfunctional HDL failed to prevent LDL auto-oxidation and enhanced it.
  • Enhanced MMP-9 activity was selectively found in dysfunctional HDL, confirmed by Western blot.
  • Dysfunctional HDL induced pro-inflammatory responses in monocytes/macrophages (increased TNF-α, decreased IL-10).
  • In vitro incubation demonstrated MMP-9's role in HDL dysfunction.

Conclusions:

  • A novel association between MMP-9 and dysfunctional HDL was identified.
  • MMP-9 contributes to the pro-inflammatory properties of dysfunctional HDL.
  • This molecular connection may elevate cardiovascular disease risk in individuals with dysfunctional HDL.
Abstract